Healthcare companies leverage social media to educate patients, promote wellness, and spotlight medical innovations.
In the last 30 days, the average company in this landscape has grown their audience by <0.1%. Biologics by McKesson grew faster than everyone else, with 0.5% growth! On average, each post in this landscape earns more than 75.9 engagements. Abbott is topping the charts with more than 177.4 engagements per post on their 14 posts in the last 30 days.
What's your ideal combo? #thisand
The puzzle pieces are starting to fall into place for more efficient and effective Alzheimer's diagnosis. 🧩 Innovative blood-based biomarker tests, now being developed, are giving clinicians the tools they need to reliably diagnose Alzheimer's Disease (AD). This advancement means hopeful changes are ahead for early intervention and improved patient outcomes. Access the full article to learn …
Do you know what it's like to live with diabetes? It can be challenging to reflect on what you may not be familiar with. But with knowledge comes power: Everyone can empower people with diabetes to access the care they need. Learn more about #AboveTheBias and how you can make a difference at our link in bio.
See the full story on Live Magazine – Link in Bio When Marc had his first heart attack the incident was not only unexpected but seemed unexplainable. Only later was it discovered that he has a genetic condition that increases the risk of cardiovascular disease. #knowlpa #cvd #cardiovasculardisease
Congratulations to our very own Tomas Cihlar, Senior Vice President of Research, Virology, for being named to TIME's list of the 100 Most Influential People in the World. His inclusion is an incredible honor and represents the work of hundreds of his Gilead colleagues and external partners, as well as nearly 20 years of groundbreaking …
We’re back with the highly anticipated bonus episodes of Science Will Win Season 4 — recorded live at SXSW! 🎙️🎉 In this special 3-part series, our amazing guests explore how AI and digital tools are empowering patients and how collaboration is key in the fight to out do cancer. 💡💪 🎧 Subscribe now and hit the link …
How can digital solutions be fit for purpose for healthcare professionals, while compatible with local infrastructures and care practices? In the latest episode of Cardio Insights hosted by Mathieu Chaffard, Sara Zimbardo shares her expertise in developing digital solutions that integrate seamlessly into diverse clinical workflows and infrastructures. Drawing from her work as Senior User Experience Designer …
Cell therapy is a cutting-edge treatment option for patients with difficult-to-treat cancers. See how we are committed to harnessing the best science to improve treatment options and broaden access to cell therapy for patients globally at the link in bio.
“One of the great things about working in an industry where what we do matters is that there's a level of commitment and passion that everybody has at the company, for the patients and the medicines and really the overall mission that we have as a company.” In the first episode of Trials to Transformation, Chris …
The Pfizer Foundation’s mission is to help build healthier communities around the world. We invest in community-led partnerships and solutions to address today’s complex global health challenges, respond to urgent health needs, and empower Pfizer colleagues to make an impact where they live, work, and beyond. #GlobalHealth #HealthEquity #PublicHealth
Save on Easter with buy 1, get 1 for $1 on select candy at CVS®.
Your gut affects more than just your stomach. Check out this article to see how it can affect your health: https://cvs.co/4bihXmM
Cell therapy is a cutting-edge treatment option for patients with difficult-to-treat cancers. We are committed to harnessing the best science to improve treatment options and broaden access to cell therapy for patients globally: https://social.jnj.com/4jetsPj
“One of the great things about working in an industry where what we do matters is that there's a level of commitment and passion that everybody has at the company, for the patients and the medicines and really the overall mission that we have as a company.” Learn more about the ways that our own Chris …
“Working with the people on the street brings me hope because, we see where they are at, and we get to see where they end up. Where they're at is not the end. And that brings me a lot of hope.” Street Outreach Teams volunteer Stanley Stinson speaks on the power of consistency and compassion in …
We invited Bin and Daniel, both #cancer survivors, to meet for the first time on-camera and discuss their survivorship journeys. This sparked an important conversation about loneliness, stigmas surrounding masculinity, and what it means to be “macho” after a life-changing diagnosis. Watch their full conversation and find resources on Survivorship Today. https://bit.ly/3RBAUHU
We are celebrating the impact of the hemophilia community and the powerful partnerships driving change. See how an effort we are proud to support is driving mentorship and connection to make a difference for people living with hemophilia: https://on.pfizer.com/4jt5dMM World Federation of Hemophilia #WHD2025 #WorldHemophiliaDay #TreatmentForAll
We’re joining the Esophageal Cancer Action Network and advocates around the world to light up the sky in periwinkle for #EsophagealCancerAwarenessMonth. The ribbon sculpture at our Foster City headquarters is a visible reflection of our commitment to advancing research and driving scientific innovation to expand treatment options for people living with cancer. At Gilead, we’re focused …
We had a great time at this year's #ONSCongress! It was good to connect with our peers and highlight the pivotal role that oncology nurses play in cancer care. Thank you to the Oncology Nursing Society and all of the presenters! Hayley Nusser, Research Coordinator at Biologics, noted that "ONS Congress 2025 was an incredible gathering …
Congratulations to our very own Tomas Cihlar, Senior Vice President of Research, Virology, for being named to TIME's list of the 100 Most Influential People in the World. His inclusion is an incredible honor and represents the work of hundreds of his Gilead colleagues and external partners, as well as nearly 20 years of groundbreaking …
We know that cost can be a big hurdle for patients. In fact, a recent report (2025 Medication Access Report: From Barriers to Bridges) from CoverMyMeds found that 54% of patients are concerned about medication costs. That's why we help patients get the financial support they need to stay on their medications. You don't have to …
Stanley knows what it’s like to wake up surrounded by snow, unable to get warm. That’s why he founded Street Outreach Teams in Detroit – so that he can help be there for those who need it the most. See how he’s taking action from @DirectRelief and The @Pfizer Foundation.
15 Likes • 4 RetweetsAt #BHPS2025, we joined health leaders and advocates to discuss the future of HIV prevention and to drive meaningful action. By working with the communities most affected, we aim to ensure everyone receives the care and services they need to help end the #HIV epidemic. pic.x.com/Mabi22RVAw
#MEDIA: The U.S. FDA approved an update to the required echo monitoring for our first-in-class treatment for adults living with symptomatic obstructive #HypertrophicCardiomyopathy: bit.ly/3YCuKuZ pic.x.com/fn9PoxIDcJ
We’re expanding our portfolio of life-changing tech with important advancements in cardiovascular care. More on $ABT earnings: abbo.tt/4jaCBrU pic.x.com/HbKm3jDCC6
This #WorldHemophiliaDay we are celebrating the hemophilia community and the powerful partnerships that are driving change. Watch how one such partnership is making a difference for people living with hemophilia: on.pfizer.com/3Gomg4o @wfhemophilia #WHD2025 #TreatmentForAll pic.x.com/QyrGuZkYla
Congratulations to Tomas Cihlar, Senior Vice President of Research, Virology, for being named to TIME's list of the 100 Most Influential People in the World. This honors nearly 20 years of #HIV research and development and the progress in helping end the epidemic. #TIME100 pic.x.com/fuuqXkHOEY
Our uniquely diversified business model delivered top-tier growth in Q1 and is helping us navigate through periods of uncertainty. More on $ABT #earnings: abbo.tt/4lxtdjN pic.x.com/8aAO7C1MFX
🎙️Out now! The bonus episodes of Science Will Win Season 4 recorded at SXSW are live! Hear how digital tools are empowering patients & how teamwork is key in the fight to out do cancer. Tune in on your favorite podcast app! 🎧 on.pfizer.com/42g1QmR pic.x.com/B0FijUnOB5
Join our Q1 2025 #earnings call and webcast now: social.jnj.com/4cuf3vO $JNJ pic.x.com/u8pJ7rn7aO
#MEDIA – We are pleased the EC has approved our first-of-a-kind bispecific antibody combination, for an aggressive form of #lymphoma, offering an off-the-shelf option for patients whose cancer returns or doesn’t respond to initial treatment. spkl.io/6016fx6sp $RHHBY $ROG pic.x.com/EbUo8ImfNN
Listen in as our leaders discuss Q1 results on the $ABT #earnings call at 8 am CT. abbo.tt/4ikzSv4 pic.x.com/5f2ctuBpZC
Congrats to the Huskers on winning “The We Give Blood Drive” and for helping us save lives! #GBR 🩸💪 x.com/bigtennetwork/…
1 Likes • 0 RetweetsReady to see how you stack up to your industry’s top social performers? Review the latest metrics on channels, engagement, post types, and more.